 Global Cell and Gene Therapy CDMO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy CDMO Services market size was US$ 9999 million in 2025 and is forecast to reach a readjusted size of US$ 71410 million by 2032 with a CAGR of 32.9% during the forec... もっと見る
SummaryThe global Cell and Gene Therapy CDMO Services market size was US$ 9999 million in 2025 and is forecast to reach a readjusted size of US$ 71410 million by 2032 with a CAGR of 32.9% during the forecast period 2026-2032.Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively. Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics. Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future. The global Cell and Gene Therapy CDMO Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032. Market Segmentation By Company: Catalent Lonza Thermo Fisher WuXi AppTec Charles River OxfordBioMedica BrammerBio CELLfor CURE OBiO Technology GenScript Esco Nikon FUJIFILM Pharmaron Porton Medicilon JOINN Laboratories Sofpromed eXmoor OmniaBio RoslinCT BioCentriq PolTREG Miltenyi Bioindustry Segment by Type Autologous Cell Therapy Products Allogeneic Cell Therapy Products Segment by Application SMBs Large Companies By Region Macro-Region - North America - Europe - Asia-Pacific - South America - Middle East & Africa Micro-Local Markets North America Europe Asia-Pacific Latin America Middle East & Africa (Additional regions can be customized based on client needs.) Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term) Chapter 2: Quantitative analysis of Cell and Gene Therapy CDMO Services market size and growth potential at global, regional, and country levels Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus) Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities Chapter 6: Regional revenue breakdown by company, type, application and customer Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies Chapter 9: Actionable conclusions and strategic recommendations. Why This Report? Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cell and Gene Therapy CDMO Services value chain, addressing: - Market entry risks/opportunities by region - Product mix optimization based on local practices - Competitor tactics in fragmented vs. consolidated markets Table of Contents1 Report Overview1.1 Study Scope 1.2 Market by Type 1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032 1.2.2 Autologous Cell Therapy Products 1.2.3 Allogeneic Cell Therapy Products 1.3 Market by Application 1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032 1.3.2 SMBs 1.3.3 Large Companies 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Cell and Gene Therapy CDMO Services Market Perspective (2021-2032) 2.2 Global Market Size by Region: 2021 vs 2025 vs 2032 2.3 Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Region (2021-2026) 2.4 Global Cell and Gene Therapy CDMO Services Revenue Forecast by Region (2027-2032) 2.5 Major Regions and Emerging Markets Analysis 2.5.1 North America Cell and Gene Therapy CDMO Services Market Size and Prospective (2021-2032) 2.5.2 Europe Cell and Gene Therapy CDMO Services Market Size and Prospective (2021-2032) 2.5.3 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size and Prospective (2021-2032) 2.5.4 Latin America Cell and Gene Therapy CDMO Services Market Size and Prospective (2021-2032) 2.5.5 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size and Prospective (2021-2032) 3 Breakdown Data by Type 3.1 Global Cell and Gene Therapy CDMO Services Historical Market Size by Type (2021-2026) 3.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2027-2032) 3.3 Representative Players for Different Types of Cell and Gene Therapy CDMO Services 4 Breakdown Data by Application 4.1 Global Cell and Gene Therapy CDMO Services Historical Market Size by Application (2021-2026) 4.2 Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2027-2032) 4.3 New Sources of Growth in Cell and Gene Therapy CDMO Services Applications 5 Competitive Landscape by Players 5.1 Global Top Players by Revenue 5.1.1 Global Top Cell and Gene Therapy CDMO Services Players by Revenue (2021-2026) 5.1.2 Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Players (2021-2026) 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 5.3 Players Covered: Ranking by Cell and Gene Therapy CDMO Services Revenue 5.4 Global Cell and Gene Therapy CDMO Services Market Concentration Analysis 5.4.1 Global Cell and Gene Therapy CDMO Services Market Concentration Ratio (CR5 and HHI) 5.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy CDMO Services Revenue in 2025 5.5 Global Key Players of Cell and Gene Therapy CDMO Services Head Offices and Areas Served 5.6 Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application 5.7 Global Key Players of Cell and Gene Therapy CDMO Services, Date of Entry into This Industry 5.8 Mergers & Acquisitions, Expansion Plans 6 Region Analysis 6.1 North America Market: Players, Segments, Downstream and Major Customers 6.1.1 North America Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) 6.1.2 North America Market Size by Type 6.1.2.1 North America Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) 6.1.2.2 North America Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) 6.1.3 North America Market Size by Application 6.1.3.1 North America Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) 6.1.3.2 North America Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) 6.1.4 North America Cell and Gene Therapy CDMO Services Major Customers 6.1.5 North America Market Trends and Opportunities 6.2 Europe Market: Players, Segments, Downstream and Major Customers 6.2.1 Europe Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) 6.2.2 Europe Market Size by Type 6.2.2.1 Europe Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) 6.2.2.2 Europe Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) 6.2.3 Europe Market Size by Application 6.2.3.1 Europe Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) 6.2.3.2 Europe Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) 6.2.4 Europe Cell and Gene Therapy CDMO Services Major Customers 6.2.5 Europe Market Trends and Opportunities 6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers 6.3.1 Asia-Pacific Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) 6.3.2 Asia-Pacific Market Size by Type 6.3.2.1 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) 6.3.2.2 Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) 6.3.3 Asia-Pacific Market Size by Application 6.3.3.1 Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) 6.3.3.2 Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) 6.3.4 Asia-Pacific Cell and Gene Therapy CDMO Services Major Customers 6.3.5 Asia-Pacific Market Trends and Opportunities 6.4 Latin America Market: Players, Segments, Downstream and Major Customers 6.4.1 Latin America Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) 6.4.2 Latin America Market Size by Type 6.4.2.1 Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) 6.4.2.2 Latin America Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) 6.4.3 Latin America Market Size by Application 6.4.3.1 Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) 6.4.3.2 Latin America Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) 6.4.4 Latin America Cell and Gene Therapy CDMO Services Major Customers 6.4.5 Latin America Market Trends and Opportunities 6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers 6.5.1 Middle East & Africa Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) 6.5.2 Middle East & Africa Market Size by Type 6.5.2.1 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) 6.5.2.2 Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) 6.5.3 Middle East & Africa Market Size by Application 6.5.3.1 Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) 6.5.3.2 Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) 6.5.4 Middle East & Africa Cell and Gene Therapy CDMO Services Major Customers 6.5.5 Middle East & Africa Market Trends and Opportunities 7 Key Player Profiles 7.1 Catalent 7.1.1 Catalent Company Details 7.1.2 Catalent Business Overview 7.1.3 Catalent Cell and Gene Therapy CDMO Services Introduction 7.1.4 Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.1.5 Catalent Recent Development 7.2 Lonza 7.2.1 Lonza Company Details 7.2.2 Lonza Business Overview 7.2.3 Lonza Cell and Gene Therapy CDMO Services Introduction 7.2.4 Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.2.5 Lonza Recent Development 7.3 Thermo Fisher 7.3.1 Thermo Fisher Company Details 7.3.2 Thermo Fisher Business Overview 7.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Introduction 7.3.4 Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.3.5 Thermo Fisher Recent Development 7.4 WuXi AppTec 7.4.1 WuXi AppTec Company Details 7.4.2 WuXi AppTec Business Overview 7.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Introduction 7.4.4 WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.4.5 WuXi AppTec Recent Development 7.5 Charles River 7.5.1 Charles River Company Details 7.5.2 Charles River Business Overview 7.5.3 Charles River Cell and Gene Therapy CDMO Services Introduction 7.5.4 Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.5.5 Charles River Recent Development 7.6 OxfordBioMedica 7.6.1 OxfordBioMedica Company Details 7.6.2 OxfordBioMedica Business Overview 7.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Introduction 7.6.4 OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.6.5 OxfordBioMedica Recent Development 7.7 BrammerBio 7.7.1 BrammerBio Company Details 7.7.2 BrammerBio Business Overview 7.7.3 BrammerBio Cell and Gene Therapy CDMO Services Introduction 7.7.4 BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.7.5 BrammerBio Recent Development 7.8 CELLfor CURE 7.8.1 CELLfor CURE Company Details 7.8.2 CELLfor CURE Business Overview 7.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Introduction 7.8.4 CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.8.5 CELLfor CURE Recent Development 7.9 OBiO Technology 7.9.1 OBiO Technology Company Details 7.9.2 OBiO Technology Business Overview 7.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Introduction 7.9.4 OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.9.5 OBiO Technology Recent Development 7.10 GenScript 7.10.1 GenScript Company Details 7.10.2 GenScript Business Overview 7.10.3 GenScript Cell and Gene Therapy CDMO Services Introduction 7.10.4 GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.10.5 GenScript Recent Development 7.11 Esco 7.11.1 Esco Company Details 7.11.2 Esco Business Overview 7.11.3 Esco Cell and Gene Therapy CDMO Services Introduction 7.11.4 Esco Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.11.5 Esco Recent Development 7.12 Nikon 7.12.1 Nikon Company Details 7.12.2 Nikon Business Overview 7.12.3 Nikon Cell and Gene Therapy CDMO Services Introduction 7.12.4 Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.12.5 Nikon Recent Development 7.13 FUJIFILM 7.13.1 FUJIFILM Company Details 7.13.2 FUJIFILM Business Overview 7.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Introduction 7.13.4 FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.13.5 FUJIFILM Recent Development 7.14 Pharmaron 7.14.1 Pharmaron Company Details 7.14.2 Pharmaron Business Overview 7.14.3 Pharmaron Cell and Gene Therapy CDMO Services Introduction 7.14.4 Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.14.5 Pharmaron Recent Development 7.15 Porton 7.15.1 Porton Company Details 7.15.2 Porton Business Overview 7.15.3 Porton Cell and Gene Therapy CDMO Services Introduction 7.15.4 Porton Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.15.5 Porton Recent Development 7.16 Medicilon 7.16.1 Medicilon Company Details 7.16.2 Medicilon Business Overview 7.16.3 Medicilon Cell and Gene Therapy CDMO Services Introduction 7.16.4 Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.16.5 Medicilon Recent Development 7.17 JOINN Laboratories 7.17.1 JOINN Laboratories Company Details 7.17.2 JOINN Laboratories Business Overview 7.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Introduction 7.17.4 JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.17.5 JOINN Laboratories Recent Development 7.18 Sofpromed 7.18.1 Sofpromed Company Details 7.18.2 Sofpromed Business Overview 7.18.3 Sofpromed Cell and Gene Therapy CDMO Services Introduction 7.18.4 Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.18.5 Sofpromed Recent Development 7.19 eXmoor 7.19.1 eXmoor Company Details 7.19.2 eXmoor Business Overview 7.19.3 eXmoor Cell and Gene Therapy CDMO Services Introduction 7.19.4 eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.19.5 eXmoor Recent Development 7.20 OmniaBio 7.20.1 OmniaBio Company Details 7.20.2 OmniaBio Business Overview 7.20.3 OmniaBio Cell and Gene Therapy CDMO Services Introduction 7.20.4 OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.20.5 OmniaBio Recent Development 7.21 RoslinCT 7.21.1 RoslinCT Company Details 7.21.2 RoslinCT Business Overview 7.21.3 RoslinCT Cell and Gene Therapy CDMO Services Introduction 7.21.4 RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.21.5 RoslinCT Recent Development 7.22 BioCentriq 7.22.1 BioCentriq Company Details 7.22.2 BioCentriq Business Overview 7.22.3 BioCentriq Cell and Gene Therapy CDMO Services Introduction 7.22.4 BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.22.5 BioCentriq Recent Development 7.23 PolTREG 7.23.1 PolTREG Company Details 7.23.2 PolTREG Business Overview 7.23.3 PolTREG Cell and Gene Therapy CDMO Services Introduction 7.23.4 PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.23.5 PolTREG Recent Development 7.24 Miltenyi Bioindustry 7.24.1 Miltenyi Bioindustry Company Details 7.24.2 Miltenyi Bioindustry Business Overview 7.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Introduction 7.24.4 Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) 7.24.5 Miltenyi Bioindustry Recent Development 8 Cell and Gene Therapy CDMO Services Market Dynamics 8.1 Cell and Gene Therapy CDMO Services Industry Trends 8.2 Cell and Gene Therapy CDMO Services Market Drivers 8.3 Cell and Gene Therapy CDMO Services Market Challenges 8.4 Cell and Gene Therapy CDMO Services Market Restraints 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer List of Tables/GraphsList of TablesTable 1. Global Cell and Gene Therapy CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032 Table 2. Global Cell and Gene Therapy CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032 Table 3. Global Market Cell and Gene Therapy CDMO Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032 Table 4. Global Cell and Gene Therapy CDMO Services Revenue (US$ Million) Market Share by Region (2021-2026) Table 5. Global Cell and Gene Therapy CDMO Services Revenue Share by Region (2021-2026) Table 6. Global Cell and Gene Therapy CDMO Services Revenue (US$ Million) Forecast by Region (2027-2032) Table 7. Global Cell and Gene Therapy CDMO Services Revenue Share Forecast by Region (2027-2032) Table 8. Global Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 9. Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Type (2021-2026) Table 10. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 11. Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Type (2027-2032) Table 12. Representative Players of Each Type Table 13. Global Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 14. Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Application (2021-2026) Table 15. Global Cell and Gene Therapy CDMO Services Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 16. Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Application (2027-2032) Table 17. New Sources of Growth in Cell and Gene Therapy CDMO Services Applications Table 18. Global Cell and Gene Therapy CDMO Services Revenue by Players (2021-2026) & (US$ Million) Table 19. Global Cell and Gene Therapy CDMO Services Market Share by Players (2021-2026) Table 20. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2025) Table 21. Ranking of Global Top Cell and Gene Therapy CDMO Services Companies by Revenue (US$ Million) in 2025 Table 22. Global 5 Largest Players Market Share by Cell and Gene Therapy CDMO Services Revenue (CR5 and HHI) & (2021-2026) Table 23. Global Key Players of Cell and Gene Therapy CDMO Services, Headquarters and Area Served Table 24. Global Key Players of Cell and Gene Therapy CDMO Services, Product and Application Table 25. Global Key Players of Cell and Gene Therapy CDMO Services, Date of Entry into This Industry Table 26. Mergers & Acquisitions, Expansion Plans Table 27. North America Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) & (US$ Million) Table 28. North America Cell and Gene Therapy CDMO Services Market Share by Revenue, by Company (2021-2026) Table 29. North America Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 30. North America Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 31. Europe Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) & (US$ Million) Table 32. Europe Cell and Gene Therapy CDMO Services Market Share by Revenue, by Company (2021-2026) Table 33. Europe Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 34. Europe Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 35. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) & (US$ Million) Table 36. Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Revenue, by Company (2021-2026) Table 37. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 38. Asia-Pacific Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 39. Latin America Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) & (US$ Million) Table 40. Latin America Cell and Gene Therapy CDMO Services Market Share by Revenue, by Company (2021-2026) Table 41. Latin America Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 42. Latin America Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 43. Middle East & Africa Cell and Gene Therapy CDMO Services Revenue by Company (2021-2026) & (US$ Million) Table 44. Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Revenue, by Company (2021-2026) Table 45. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 46. Middle East & Africa Cell and Gene Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 47. Catalent Company Details Table 48. Catalent Business Overview Table 49. Catalent Cell and Gene Therapy CDMO Services Product Table 50. Catalent Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 51. Catalent Recent Development Table 52. Lonza Company Details Table 53. Lonza Business Overview Table 54. Lonza Cell and Gene Therapy CDMO Services Product Table 55. Lonza Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 56. Lonza Recent Development Table 57. Thermo Fisher Company Details Table 58. Thermo Fisher Business Overview Table 59. Thermo Fisher Cell and Gene Therapy CDMO Services Product Table 60. Thermo Fisher Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 61. Thermo Fisher Recent Development Table 62. WuXi AppTec Company Details Table 63. WuXi AppTec Business Overview Table 64. WuXi AppTec Cell and Gene Therapy CDMO Services Product Table 65. WuXi AppTec Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 66. WuXi AppTec Recent Development Table 67. Charles River Company Details Table 68. Charles River Business Overview Table 69. Charles River Cell and Gene Therapy CDMO Services Product Table 70. Charles River Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 71. Charles River Recent Development Table 72. OxfordBioMedica Company Details Table 73. OxfordBioMedica Business Overview Table 74. OxfordBioMedica Cell and Gene Therapy CDMO Services Product Table 75. OxfordBioMedica Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 76. OxfordBioMedica Recent Development Table 77. BrammerBio Company Details Table 78. BrammerBio Business Overview Table 79. BrammerBio Cell and Gene Therapy CDMO Services Product Table 80. BrammerBio Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 81. BrammerBio Recent Development Table 82. CELLfor CURE Company Details Table 83. CELLfor CURE Business Overview Table 84. CELLfor CURE Cell and Gene Therapy CDMO Services Product Table 85. CELLfor CURE Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 86. CELLfor CURE Recent Development Table 87. OBiO Technology Company Details Table 88. OBiO Technology Business Overview Table 89. OBiO Technology Cell and Gene Therapy CDMO Services Product Table 90. OBiO Technology Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 91. OBiO Technology Recent Development Table 92. GenScript Company Details Table 93. GenScript Business Overview Table 94. GenScript Cell and Gene Therapy CDMO Services Product Table 95. GenScript Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 96. GenScript Recent Development Table 97. Esco Company Details Table 98. Esco Business Overview Table 99. Esco Cell and Gene Therapy CDMO Services Product Table 100. Esco Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 101. Esco Recent Development Table 102. Nikon Company Details Table 103. Nikon Business Overview Table 104. Nikon Cell and Gene Therapy CDMO Services Product Table 105. Nikon Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 106. Nikon Recent Development Table 107. FUJIFILM Company Details Table 108. FUJIFILM Business Overview Table 109. FUJIFILM Cell and Gene Therapy CDMO Services Product Table 110. FUJIFILM Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 111. FUJIFILM Recent Development Table 112. Pharmaron Company Details Table 113. Pharmaron Business Overview Table 114. Pharmaron Cell and Gene Therapy CDMO Services Product Table 115. Pharmaron Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 116. Pharmaron Recent Development Table 117. Porton Company Details Table 118. Porton Business Overview Table 119. Porton Cell and Gene Therapy CDMO Services Product Table 120. Porton Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 121. Porton Recent Development Table 122. Medicilon Company Details Table 123. Medicilon Business Overview Table 124. Medicilon Cell and Gene Therapy CDMO Services Product Table 125. Medicilon Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 126. Medicilon Recent Development Table 127. JOINN Laboratories Company Details Table 128. JOINN Laboratories Business Overview Table 129. JOINN Laboratories Cell and Gene Therapy CDMO Services Product Table 130. JOINN Laboratories Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 131. JOINN Laboratories Recent Development Table 132. Sofpromed Company Details Table 133. Sofpromed Business Overview Table 134. Sofpromed Cell and Gene Therapy CDMO Services Product Table 135. Sofpromed Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 136. Sofpromed Recent Development Table 137. eXmoor Company Details Table 138. eXmoor Business Overview Table 139. eXmoor Cell and Gene Therapy CDMO Services Product Table 140. eXmoor Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 141. eXmoor Recent Development Table 142. OmniaBio Company Details Table 143. OmniaBio Business Overview Table 144. OmniaBio Cell and Gene Therapy CDMO Services Product Table 145. OmniaBio Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 146. OmniaBio Recent Development Table 147. RoslinCT Company Details Table 148. RoslinCT Business Overview Table 149. RoslinCT Cell and Gene Therapy CDMO Services Product Table 150. RoslinCT Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 151. RoslinCT Recent Development Table 152. BioCentriq Company Details Table 153. BioCentriq Business Overview Table 154. BioCentriq Cell and Gene Therapy CDMO Services Product Table 155. BioCentriq Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 156. BioCentriq Recent Development Table 157. PolTREG Company Details Table 158. PolTREG Business Overview Table 159. PolTREG Cell and Gene Therapy CDMO Services Product Table 160. PolTREG Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 161. PolTREG Recent Development Table 162. Miltenyi Bioindustry Company Details Table 163. Miltenyi Bioindustry Business Overview Table 164. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Table 165. Miltenyi Bioindustry Revenue in Cell and Gene Therapy CDMO Services Business (2021-2026) & (US$ Million) Table 166. Miltenyi Bioindustry Recent Development Table 167. Cell and Gene Therapy CDMO Services Market Trends Table 168. Cell and Gene Therapy CDMO Services Market Drivers Table 169. Cell and Gene Therapy CDMO Services Market Challenges Table 170. Cell and Gene Therapy CDMO Services Market Restraints Table 171. Research Programs/Design for This Report Table 172. Key Data Information from Secondary Sources Table 173. Key Data Information from Primary Sources List of Figures Figure 1. Cell and Gene Therapy CDMO Services Product Picture Figure 2. Global Cell and Gene Therapy CDMO Services Market Share by Type: 2025 vs 2032 Figure 3. Autologous Cell Therapy Products Features Figure 4. Allogeneic Cell Therapy Products Features Figure 5. Global Cell and Gene Therapy CDMO Services Market Share by Application: 2025 vs 2032 Figure 6. SMBs Figure 7. Large Companies Figure 8. Cell and Gene Therapy CDMO Services Report Years Considered Figure 9. Global Cell and Gene Therapy CDMO Services Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 10. Global Cell and Gene Therapy CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032 Figure 11. Global Cell and Gene Therapy CDMO Services Market Share by Revenue, by Region: 2021 vs 2025 Figure 12. North America Cell and Gene Therapy CDMO Services Revenue (US$ Million) Growth Rate (2021-2032) Figure 13. Europe Cell and Gene Therapy CDMO Services Revenue (US$ Million) Growth Rate (2021-2032) Figure 14. Asia-Pacific Cell and Gene Therapy CDMO Services Revenue (US$ Million) Growth Rate (2021-2032) Figure 15. Latin America Cell and Gene Therapy CDMO Services Revenue (US$ Million) Growth Rate (2021-2032) Figure 16. Middle East & Africa Cell and Gene Therapy CDMO Services Revenue (US$ Million) Growth Rate (2021-2032) Figure 17. Global Cell and Gene Therapy CDMO Services Market Share by Players in 2025 Figure 18. Global Top Cell and Gene Therapy CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2025) Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy CDMO Services Revenue in 2025 Figure 20. North America Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) Figure 21. North America Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) Figure 22. Europe Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) Figure 23. Europe Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) Figure 24. Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) Figure 25. Asia-Pacific Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) Figure 26. Latin America Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) Figure 27. Latin America Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) Figure 28. Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Type (2021-2026) Figure 29. Middle East & Africa Cell and Gene Therapy CDMO Services Market Share by Application (2021-2026) Figure 30. Catalent Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 31. Lonza Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 32. Thermo Fisher Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 33. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 34. Charles River Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 35. OxfordBioMedica Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 36. BrammerBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 37. CELLfor CURE Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 38. OBiO Technology Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 39. GenScript Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 40. Esco Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 41. Nikon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 42. FUJIFILM Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 43. Pharmaron Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 44. Porton Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 45. Medicilon Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 46. JOINN Laboratories Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 47. Sofpromed Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 48. eXmoor Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 49. OmniaBio Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 50. RoslinCT Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 51. BioCentriq Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 52. PolTREG Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 53. Miltenyi Bioindustry Revenue Growth Rate in Cell and Gene Therapy CDMO Services Business (2021-2026) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD（gene）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
